Old Web
English
Sign In
Acemap
>
authorDetail
>
Emma Guttman
Emma Guttman
Rockefeller University
Medicine
Psoriasis
Tumor necrosis factor alpha
Loricrin
Immunology
4
Papers
130
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
28081 Strategies to improve quality of atopic dermatitis care in North America: Results from the Atopic Dermatitis Quality of Care (ADQoC) initiative
2021
Journal of The American Academy of Dermatology
Peter A. Lio
Lawrence F. Eichenfield
Emma Guttman
Vincent Piguet
Eric L. Simpson
Show All
Source
Cite
Save
Citations (0)
15274 Dupilumab improves patient-reported global assessments of disease severity and treatment effect: Data from a 16-week phase 3 placebo-controlled trial in adolescent patients with moderate to severe AD (LIBERTY AD ADOL)
2020
Journal of The American Academy of Dermatology
Eric L. Simpson
Emma Guttman
Ashish Bansal
Zhen Chen
Ana Beatris Rossi
Abhijit Gadkari
Show All
Source
Cite
Save
Citations (0)
15108 Long-term efficacy and safety of dupilumab in adolescents with atopic dermatitis: Results from an open-label extension trial (LIBERTY AD PED-OLE)
2020
Journal of The American Academy of Dermatology
Andrew Blauvelt
Emma Guttman
Iftikhar Hussain
Zhen Chen
Paola Mina-Osorio
Ana Beatris Rossi
Sanofi Genzyme
Ashish Bansal
Show All
Source
Cite
Save
Citations (0)
TNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin Barrier
2011
Journal of Investigative Dermatology
Byung Eui Kim
Michael D. Howell
Emma Guttman
Patricia Gilleaudeau
Irma Cardinale
Mark Boguniewicz
James G. Krueger
Donald Y.M. Leung
Show All
Source
Cite
Save
Citations (130)
1